Predictive Factors and Outcome in Medical Thoracoscopy

December 29, 2016 updated by: Yserbyt Jonas, KU Leuven
Retrospective survey for factors predicting the outcome of medical thoracoscopy

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Retrospective survey for factors predicting the outcome of medical thoracoscopy in patients with malignant pleuritis

Study Type

Observational

Enrollment (Actual)

155

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Belgium
      • Leuven, Belgium, 3000
        • UZ Leuven

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

pulmonary or extrathoracic malignancy

Description

Inclusion Criteria:

  • progressive malignancy
  • pleuritis

Exclusion Criteria:

  • respiratory failure
  • unable to consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
responders
amelioration of dyspnea radiological amelioration after sterile talc pleurodesis
Drug: sterile talc pleurodesis
medical thoracoscopy and talc pleurodesis. No specific device is studied.
Other Names:
  • medical thoracoscopy
failed intervention
unchanged symptoms and radiology after sterile talc pleurodesis
Drug: sterile talc pleurodesis
medical thoracoscopy and talc pleurodesis. No specific device is studied.
Other Names:
  • medical thoracoscopy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Chest X-ray
Time Frame: 3 months
radiological resolution of pleuritis; 3 level severity grading (A, B, C, with C as worst grade)
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
time interval
Time Frame: 12 months
survival in months
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

KU Leuven

Investigators

  • Principal Investigator: Jonas Yserbyt, UZ Leuven

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2014

Primary Completion (Actual)

December 1, 2016

Study Completion (Actual)

December 1, 2016

Study Registration Dates

First Submitted

November 4, 2014

First Submitted That Met QC Criteria

November 7, 2014

First Posted (Estimate)

November 11, 2014

Study Record Updates

Last Update Posted (Estimate)

December 30, 2016

Last Update Submitted That Met QC Criteria

December 29, 2016

Last Verified

December 1, 2016

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • S561430

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pleuritis

Clinical Trials on sterile talc pleurodesis

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jamaica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe